BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 28, 2008
View Archived Issues
Recent Allergan patent divulges novel antiglaucoma agents
Read More
Novel agents for treating allergic disorders disclosed in recent Array patent
Read More
Recent patents describe novel antidepressant and antipsychotic agents
Read More
ARRY-520 shows less chemoresistance-inducing potential than paclitaxel in vitro
Read More
Novel erbB2 inhibitor shows efficacy in different preclinical cancer models
Read More
Preclinical profile of Wyeth's novel progesterone receptor modulator
Read More
Novel GnRH allosteric modulator discovered at Organon
Read More
Vermillion announces positive results from clinical trial of ovarian tumor triage test
Read More
Oncolin changes name from Edgeline Holdings and provides update on activities
Read More
Ardea presents update on its 2008 plans
Read More
Sonus refines strategic initiatives and focuses on development of SN-2310 in cancer
Read More
Targeted Genetics reports interim data from phase I/II clinical trial of tgAAC-94
Read More
Genentech initiates clinical development in the U.S. and U.K. of cancer drug GDC-0941
Read More
Adherex initiates phase III trial of sodium thiosulfate for hearing loss in children
Read More
Nventa reports positive interim data from HspE7 phase I cervical dysplasia trial
Read More
AEterna Zentaris initiates second phase III trial of cetrorelix for benign prostatic hyperplasia
Read More
ExonHit announces results from phase I study of EHT-0202 for brain impairments
Read More
Lorus initiates toxicology studies of anticancer drug LOR-253
Read More
Oxigene initiates dosing in phase II study of Zybrestat for NSCLC
Read More
Roswell Park Cancer Institute awarded USD 900,000 grant for ovarian cancer vaccine
Read More
Trubion provides update on product pipeline
Read More
European Commission approves novel oral anticoagulant Pradaxa
Read More
Positive results for VX-770, Vertex's cystic fibrosis protein modulator
Read More